Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 17, 2001JAMA

High-Dose Antithrombin III in Severe Sepsis

View Full Paper
Ask AI
Bookmark
Share

Authors

BWBrian WarrenMerck & Co., Inc., Rahway, NJ, USA (United States)AEAlain EidMemorial HospitalPSPierre SingerReichman University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Warren et al. (2001) studied this question.

synapsesocial.com/papers/6a80ff32407ce5842fa8b2bfhttps://doi.org/10.1001/jama.286.15.1869
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Disseminated Intravascular Coagulation Is a Frequent Complication of Systemic Inflammatory Response Syndrome1996 · 198 citations
  2. 2Antithrombin III in Animal Models of Sepsis and Organ Failure1998 · 71 citations
  3. 3The contact system contributes to hypotension but not disseminated intravascular coagulation in lethal bacteremia. In vivo use of a monoclonal anti-factor XII antibody to block contact activation in baboons.1993 · 280 citations
  4. 4Initiation of the tissue factor pathway of coagulation in the presence of heparin: control by antithrombin III and tissue factor pathway inhibitor1996 · 58 citations